Actively Recruiting
Study Comparing How Well Current Staging Systems Predict Outcomes in Cutaneous Squamous Cell Carcinoma
Led by Queen Mary University of London · Updated on 2026-04-02
1500
Participants Needed
2
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Cutaneous squamous cell carcinoma CSCC is the second most common type of skin cancer and one of the most frequently diagnosed cancers worldwide. While most CSCC cases are successfully treated with surgery and have a good outlook, a small number of cases have poor outcomes, including spreading to other parts of the body and death. Researchers aim to evaluate how well current staging systems predict these poor outcomes and explore whether better prediction tools can be developed. This is an observational study involving people diagnosed with CSCC from two UK dermatology centers. Researchers will review existing cases to assess the accuracy of current histological staging classifications in predicting the risk of recurrence or metastasis within four years. In the second part of the study, they will investigate if improved prediction methods can be identified. Participants will have their medical information reviewed, focusing on disease outcomes over time. No treatments or interventions are given as part of the study. The main measure is whether the cancer comes back or spreads within four years. The study allows for long-term follow-up and includes adults aged 18 to 120 years. All data collected will help improve future patient management and care.
CONDITIONS
Brief Title
Cutaneous Squamous Cell Carcinoma Staging Study
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here